Meet us at TRI-CON 2024 and learn about Virtuoso, our epigenomic platform that provides an unprecedented level of clarity to inform cancer diagnosis and treatment.

Plus, don’t miss our presentation!

Epigenomic Tools for Early Cancer Detection & Therapy Response
March 26, 3-3:15pm
Gulfem D. Guler
Senior Director, Translational Research

Stop by our Booth #224 at Precision Med TRI-CON 2024 in San Diego, March 26-28, to learn more about our technology and solutions.
Please get in touch with us directly if you would like to ask us any questions in advance of the conference. We look forward to talking with you!


About ClearNote Health

ClearNote Health is a cancer detection company focused on enabling people at risk for high-mortality cancers to live longer healthier lives. Utilizing a standard blood draw, the company applies its proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops. With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases, ClearNote Health identifies cancers before they progress and when patients are most likely to benefit from treatment. ClearNote Health is headquartered in San Diego, with additional presence in the San Francisco Bay area and internationally. The company’s CLIA- and CAP-accredited laboratory is located in San Diego, Calif.